share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer Denton David M

輝瑞 | 4:持股變動聲明-高管 Denton David M
美股sec公告 ·  06/03 18:36
Moomoo AI 已提取核心訊息
Pfizer Inc.'s Chief Financial Officer & EVP, Denton David M, completed a sale of 12,107 shares of common stock on May 31, 2024. The transaction was carried out at a price of $28.66 per share, resulting in a total value of $346,986.62. Following the sale, Denton David M's direct holdings in Pfizer common stock amounted to 37,919 shares. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
Pfizer Inc.'s Chief Financial Officer & EVP, Denton David M, completed a sale of 12,107 shares of common stock on May 31, 2024. The transaction was carried out at a price of $28.66 per share, resulting in a total value of $346,986.62. Following the sale, Denton David M's direct holdings in Pfizer common stock amounted to 37,919 shares. The sale was executed to cover the payment of exercise price or tax liability by delivering or withholding securities, as indicated by the transaction code 'F'.
輝瑞公司(臨時代碼)首席財務官兼總裁Denton David M在2024年5月31日出售了12,107股普通股,每股售價28.66美元,總價值為346,986.62美元。此次交易後,Denton David M直接持有的輝瑞普通股總量為37,919股。此次出售是為了通過提供或扣除證券來支付行使價格或稅務責任,如交易代碼'F'所示。
輝瑞公司(臨時代碼)首席財務官兼總裁Denton David M在2024年5月31日出售了12,107股普通股,每股售價28.66美元,總價值為346,986.62美元。此次交易後,Denton David M直接持有的輝瑞普通股總量為37,919股。此次出售是為了通過提供或扣除證券來支付行使價格或稅務責任,如交易代碼'F'所示。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息